EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Drug-induced liver injury due to potassium iodide during thyroid storm

Noriyoshi Takano, Yasufumi Seki, Daisuke Watanabe, Atsuhiro Ichihara

JCEM Case Reports · 2026-04-21 · 4 (5)

DOI: 10.1210/jcemcr/luag053 ↗
AbstractBibliografische Angaben

Abstract

Abstract Thyroid storm is a life-threatening condition causing multiorgan failure, including liver dysfunction. Potassium iodide (KI) is one of the key drugs used to control thyroid hormone levels. While thionamides sometimes cause drug-induced liver injury (DILI), KI has not been reported to cause DILI. Herein, we report a case of likely KI-induced DILI during treatment for thyroid storm due to Graves disease. A 30-year-old man presented with thyrotoxicosis due to Graves disease, with hyperbilirubinemia and elevated liver transaminases. The patient was diagnosed with thyroid storm, and treatment was initiated with methimazole, KI, corticosteroids, and beta-blockers. Although the thyroid hormone levels improved during the treatment, total bilirubin levels increased to 32.4 mg/dL (SI: 553 µmol/L) (reference range, <1.2 mg/dL [SI: <20.5 µmol/L]). DILI was suspected, and methimazole was discontinued; however, bilirubin levels remained elevated. Plasma exchange also failed to improve the liver injury. After KI was discontinued, the bilirubin levels rapidly decreased. Lymphocyte transformation tests for methimazole and KI were negative and positive, respectively, confirming the diagnosis of KI-induced DILI. This case highlights that KI should be recognized as a potential cause of DILI in patients with KI therapy who present with abnormal liver function.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →